Recommendations for clinical use of tumor markers in lung cancer
Lung cancer presents one of the most serious problems of modern oncology Despite the continual improvement and development of diagnostic methods, in 50-70% of lung cancer patients the disease is still diagnosed in advanced stages, excluding the possibility of radical therapy. The determination of tu...
Main Author: | Stanković Sanja |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Medical Biochemists of Serbia, Belgrade
2007-01-01
|
Series: | Journal of Medical Biochemistry |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2007/0354-34470702121S.pdf |
Similar Items
-
Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers
by: Jun Ma, et al.
Published: (2021-08-01) -
Lung Cancer in Patients who Presented with Lung Nodules or Lung Masses at Chest Clinic, Phrae Hospital 2013-2016
by: Parichat Niyomthong
Published: (2017-09-01) -
Incidence and Prevalence Analysis of Non-Small-Cell and Small-Cell Lung Cancer Using Administrative Data
by: Andrea Ricotti, et al.
Published: (2021-08-01) -
Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells
by: Ugo Testa, et al.
Published: (2018-07-01) -
Association of serum follistatin levels with histological types and progression of tumor in human lung cancer
by: Pengyu Zhang, et al.
Published: (2018-10-01)